What is the main business of Hial?

The main business activity of Hial focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 18, 2023.

Where is the headquarters located?

The headquarters is located at: ul. Myśliwska 66A, 30-718 Kraków.

What is the share capital?

The share capital of the company is PLN 150,000 (approx. $40,519).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

In 2025, the company generated total revenue of $519,200, representing an increase of 186.3% compared to 2024.

Is the company profitable?

Yes, the company recorded a net profit of $111,873 in 2025, meaning the company increased its profit by 152.7%.

What is the main operating cost?

The largest operating cost category falls under other operating costs. This category amounted to $361,487 in 2025, representing 91% of all operating expenses.

Hialsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2023-08-18

Share capital

150,000.00 PLN

Activity description

Hial is a sterile medical device intended for intra-articular injection. It is produced through microbial fermentation, and each batch has a certificate of microbiological, chemical and physical analysis.

Registered address

ul. Myśliwska 66A/80, 30-718 Kraków, Poland

Website

hial.com.pl

Phone

Electronic delivery address

AE:PL-47821-91517-VADCU-34

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 82 days early. 1 of 3 audited by a statutory auditor.

202531/03/2026
202425/04/2025
202316/05/2024

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 519.20kMedianUSD 1.06mAverageUSD 22.40m

Net profit

This companyUSD 111.87kMedianUSD 37.33kAverageUSD 880.24k

Operating costs

This companyUSD 396.11kMedianUSD 922.77kAverageUSD 21.08m

Assets

This companyUSD 246.52kMedianUSD 608.93kAverageUSD 11.85m

Industry

Offer

Medical device
Intra-articular injection preparation
Sterile injectable substance

Website technology

Website

WordPress
Elementor

Authorized Representatives

Mateusz Robert Cyfra – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Mateusz Robert Cyfraage 37	1,500	$40,518.64	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2023-09-01.

Erste Bank Polska
45 1090 2750 0000 0001 5511 2734
Erste Bank Polska
65 1090 2750 0000 0001 5511 2762

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Steriwundsp. z o.o.	$2,832,891.51	steriwund.pl
Intra-Medsp. z o.o.	$2,207,002.25	intra-med.pl
Symbiochemsp. z o.o.	$1,509,917.88	symbiochem.com
Novisc Pharmasp. z o.o.	$806,018.56	novisc.com
Madmedsp. z o.o.	$426,323.50	madmed.eu
Zdrowe Stawysp. z o.o.	$236,365.48	hyalutidin.pl

Change history

Date	Event
2025-01-15	Address change (Ul. Brzezińska 6a, 42-200, Częstochowa → Ul. Myśliwska 66a/80, 30-718, Kraków)
2023-08-18	Entered in the register

FAQ

Last updated: 2026-10-07